IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
What is the purpose of this trial?
The purpose of this research study is to investigate the safety and effectiveness of botulinum toxin A (Xeomin) ® injections in patients who suffer from focal pain in areas of radiation and/or surgery as a result of cancer treatment. Our hypothesis is that injection of incobotulinum toxin A into an area of local pain, at or around the area of a post-surgical/post radiation scar, relieves the focal cancer pain.
- 18 Years - 80 Years
- Merz Pharmaceuticals
- Last Updated:
- Study HIC#: